Wipro Limited (NYSE: WIT) reported first-quarter FY24 gross revenue of $2.782 billion, an increase of 6% Y/Y, marginally beating the consensus of $2.78 billion.
Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people's lives by silencing diseases through